Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × HCC × Clear all

Phase

Phase 2 3 Phase NA 1 Phase 2/3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 3408 Neoplasms 2641 Prostatic Neoplasms 1540 Colorectal Neoplasms 1268 Lung Neoplasms 1165 Motor Activity 712 Head and Neck Neoplasms 607 Pancreatic Neoplasms 586 Uterine Cervical Neoplasms 571 Colonic Neoplasms 569 Carcinoma, Non-Small-Cell Lung 560 Carcinoma, Hepatocellular 549 Rectal Neoplasms 503 Stomach Neoplasms 477 Brain Neoplasms 418 Ovarian Neoplasms 387 Pain 367 Anxiety Disorders 367 Neoplasm Metastasis 336 Polycystic Ovary Syndrome 335 Esophageal Neoplasms 332 Urinary Bladder Neoplasms 316 Precursor Cell Lymphoblastic Leukemia-Lymphoma 306 Fatigue 293 Multiple Myeloma 285 Melanoma 283 Lymphoma 272 Depression 263 Endometrial Neoplasms 253 Liver Neoplasms 243

Interventions

Sorafenib 1 Radiofrequency Ablation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01470495 2017-03-28

REPEAT

Southwest Hospital, China

Phase NA Unknown

HCC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡